These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18768386)

  • 1. Rebeccamycin derivatives as dual DNA-damaging agents and potent checkpoint kinase 1 inhibitors.
    Marminon C; Anizon F; Moreau P; Pfeiffer B; Pierré A; Golsteyn RM; Peixoto P; Hildebrand MP; David-Cordonnier MH; Lozach O; Meijer L; Prudhomme M
    Mol Pharmacol; 2008 Dec; 74(6):1620-9. PubMed ID: 18768386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
    Conchon E; Anizon F; Aboab B; Prudhomme M
    J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolocarbazoles as checkpoint 1 kinase inhibitors.
    Hénon H; Conchon E; Hugon B; Messaoudi S; Golsteyn RM; Prudhomme M
    Anticancer Agents Med Chem; 2008 Aug; 8(6):577-97. PubMed ID: 18690823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of isogranulatimide analogues.
    Hugon B; Anizon F; Bailly C; Golsteyn RM; Pierré A; Léonce S; Hickman J; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2007 Sep; 15(17):5965-80. PubMed ID: 17582773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring.
    Messaoudi S; Anizon F; Peixoto P; David-Cordonnier MH; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2006 Nov; 14(22):7551-62. PubMed ID: 16889964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebeccamycin analogues as anti-cancer agents.
    Prudhomme M
    Eur J Med Chem; 2003 Feb; 38(2):123-40. PubMed ID: 12620658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments of rebeccamycin analogues as topoisomerase I inhibitors and antitumor agents.
    Prudhomme M
    Curr Med Chem; 2000 Dec; 7(12):1189-212. PubMed ID: 11032967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel checkpoint kinase 1 inhibitors by in vitro assays and in human cancer cells treated with topoisomerase inhibitors.
    Ferry G; Studeny A; Bossard C; Kubara PM; Zeyer D; Renaud JP; Casara P; de Nanteuil G; Wierzbicki M; Pfeiffer B; Prudhomme M; Leonce S; Pierré A; Boutin JA; Golsteyn RM
    Life Sci; 2011 Aug; 89(7-8):259-68. PubMed ID: 21736880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-step synthesis from rebeccamycin of an efficient checkpoint kinase 1 inhibitor.
    Anizon F; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Eur J Med Chem; 2009 May; 44(5):2234-8. PubMed ID: 18602198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors.
    Tao ZF; Wang L; Stewart KD; Chen Z; Gu W; Bui MH; Merta P; Zhang H; Kovar P; Johnson E; Park C; Judge R; Rosenberg S; Sowin T; Lin NH
    J Med Chem; 2007 Apr; 50(7):1514-27. PubMed ID: 17352464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.
    Zhang G; Shen J; Cheng H; Zhu L; Fang L; Luo S; Muller MT; Lee GE; Wei L; Du Y; Sun D; Wang PG
    J Med Chem; 2005 Apr; 48(7):2600-11. PubMed ID: 15801850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
    Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
    Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles.
    Conchon E; Anizon F; Aboab B; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2008 Apr; 16(8):4419-30. PubMed ID: 18321713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicities of three rebeccamycin derivatives in the National Cancer Institute screening of 60 human tumor cell lines.
    Moreau P; Holbeck S; Prudhomme M; Sausville EA
    Anticancer Drugs; 2005 Feb; 16(2):145-50. PubMed ID: 15655411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors.
    Sako Y; Ichikawa S; Osada A; Matsuda A
    Bioorg Med Chem; 2010 Nov; 18(22):7878-89. PubMed ID: 20943405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
    Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
    J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA targeting of two new antitumour rebeccamycin derivatives.
    Facompré M; Baldeyrou B; Bailly C; Anizon F; Marminon C; Prudhomme M; Colson P; Houssier C
    Eur J Med Chem; 2002 Dec; 37(12):925-32. PubMed ID: 12660017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety.
    Anizon F; Moreau P; Sancelme M; Laine W; Bailly C; Prudhomme M
    Bioorg Med Chem; 2003 Aug; 11(17):3709-22. PubMed ID: 12901916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.